Navigation Links
Lumenis(R) UltraPulse CO2 Laser to be Featured on National Television with Live Pearly Penile Papules (PPP) Procedure
Date:3/10/2009

Dr. William Groff will perform a PPP laser procedure on The Doctors national show, Tuesday, March 10, 2009. Check local listings for airtime.

SANTA CLARA, Calif., March 10 /PRNewswire/ -- Lumenis Ltd., a global developer, manufacturer and seller of laser, light-based and radio-frequency devices for surgical, aesthetic, and ophthalmic applications, announced that its UltraPulse CO2 laser will be featured on The Doctors national television show on Tuesday, March 10, 2009 as part of a live procedure performed by Dr. William Groff, a dermatologist with La Jolla Cosmetic Surgery Centre. Dr. Groff will treat Pearly Penile Papules (PPP), a condition in which small skin tags or domes form on the penis. Pearly Penile Papules (PPP) are very common and affect approximately 25% of men. PPP is not a sexually transmitted disease and is not contagious, however, it can be emotional disturbing and socially embarrassing, leading many men to seek treatment.

The cause of Pearly Penile Papules is unknown, although they are more common in men in their twenties and thirties and in men who are uncircumcised. PPP are often mistaken for genital warts and as a result, can cause stress and embarrassment.

The UltraPulse CO2 laser provides a quick, painless and permanent solution to PPP. The precision of UltraPulse allows exact vaporization of the papules without damaging the normal skin of the penis. There is no scarring and no loss of sensation and the recovery time is about 1 to 2 weeks.

"With more than 18 years of clinical experience, 34 FDA cleared indications and more than 90 peer-reviewed publications, the UltraPulse offers a safe and effective solution to men suffering from this condition," said Mr. Robert Mann, General Manager of Lumenis Global Aesthetics and Dermatology.

"While PPP is not a harmful condition, many men suffer embarrassment and humiliation in silence," said Dr. William Groff. "It is important for men to know that there is a safe, easy and effective solution."

About PPP

Pearly penile papules are small dome-shaped bumps that sometimes appear around the circumference of the penis. These bumps, or papules, are commonly skin-colored. Pearly penile papules, technically called hirsuties papillaris genitalis, are not sexually transmitted. Their cause is unknown, although they are more common in men in their twenties and thirties, and are also more common in uncircumcised males.

Some men choose to leave this condition untreated, as the papules are generally asymptomatic. However, many men find this condition to be embarrassing in intimate situations and suffer detrimental social and emotional effects from leaving the papules untreated.

Treatment for pearly penile papules is typically quite simple and effective through carbon dioxide laser treatment by a qualified dermatologist.

About Lumenis

Lumenis is Israel's largest medical device company with more than 800 employees worldwide. The Company invests heavily in R&D and holds a leading position in the markets in which it serves. Lumenis has over 250 patents worldwide, over 75 FDA clearances, worldwide presence in over 100 countries, and an installed base of over 70,000 systems. For more information about Lumenis and its products, log onto www.lumenis.com.

Lumenis(R) is a registered trademark of Lumenis Ltd.

UltraPulse(R) is a trademark of Lumenis Ltd.

    Contact:
    Michelle Maydan
    Director of Corporate Communications
    1-866-569-0597
    +972-4-959-9004
    e-mail: mmaydan@lumenis.com


'/>"/>
SOURCE Lumenis Ltd.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Lumenis(R) Introduces the Newest Innovations in Fractional CO2 Laser Skin Therapy
2. Lumenis(R) Seeks Shareholder Approval of Proposed Class Action Settlement
3. Lumenis(R) Introduces Four New Products & Delivery Devices at the 2008 American Academy of Ophthalmology Annual Meeting in Atlanta, Georgia USA
4. Lumenis(R) Introduces LightSheer(R) Duet(TM) for High Speed Permanent Hair Reduction
5. Lumenis(R) UltraPulse CO2 Laser to be Featured on National Television with Live Pearly Penile Papule (PPP) Procedure
6. Laser blasts viruses in blood
7. Skin Cooling After Laser Treatment Could Leave Marks
8. Prize for Cutting-Edge Laser Innovations
9. VNUS Medicals Patent Lawsuit Against Laser Competitors to Proceed to Trial
10. OmniGuide Announces Launch of LightPath(TM) CO2 Laser Fiber
11. Alma Lasers Answers Lumenis Complaint
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/19/2017)... ... ... Braun Industries will be participating as an exhibitor at EMS Today 2017. ... 23-25, 2017 at the Calvin L. Rampton Salt Palace Convention Center in Salt Lake ... on display. , “JEMS is a leader in EMS news and education. ...
(Date:2/19/2017)... ... February 19, 2017 , ... ... in better care, and MEDfx and the Delaware Health Information Network (DHIN) have ... As the nation’s first state-wide health information exchange, DHIN stores and shares real-time ...
(Date:2/18/2017)... ... February 17, 2017 , ... ... Axendia, **FDAnews Free Webinar**, March 1, 2017 — 1:30 p.m. – 2:30 ... regulatory burden? Pay dividends in enhanced and predictable product performance? Streamline processes ...
(Date:2/18/2017)... ... 17, 2017 , ... Butler Mobility invited Ken Matthews to visit its manufacturing ... Ken was impressed with the safety and reliability of the Stannah Stairlift as ... show. This endorsement by Ken Matthews can be heard on News Radio WHP ...
(Date:2/18/2017)... ... February 17, 2017 , ... Park Cities Pet Sitter ... Show on the Pet Life Radio network. The episode, which was posted this ... topics including: what factors led to Park Cities Pet Sitter’s being awarded the 2017 ...
Breaking Medicine News(10 mins):
(Date:2/16/2017)... Research and Markets has announced the addition of ... report to their offering. ... Traditional medical devices include devices (e.g., ... implantables, large endoscopes, needle based drug delivery, lab based diagnostics ... to three decades for the treatment and management of various ...
(Date:2/16/2017)... -- DaVita Inc. (NYSE: DVA ) today announced ... Net income attributable to DaVita Inc. for ... million, or $0.80 per share and $880 million, or $4.29 ... to DaVita Inc. for the quarter and year ended December ... million, or $0.98 per share, and $789 million, or $3.85 ...
(Date:2/16/2017)... 16, 2017  Aralez Pharmaceuticals Inc. (NASDAQ: ... today announced that executive management will participate in the ... February 22-23, 2017. Adrian Adams , Chief Executive ... 1:35 p.m. local time on Wednesday, February 22, 2017. ... the event may be accessed from the Investors section ...
Breaking Medicine Technology: